The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Clinical proteomics: A need to define the field and to begin to set adequate standards
Open accessAbstract
The aim of this manuscript is to initiate a constructive discussion about the definition of clinical proteomics, study requirements, pitfalls and (potential) use. Furthermore, we hope to stimulate proposals for the optimal use of future opportunities and seek unification of the approaches in clinical proteomic studies. We have outlined our collective views about the basic principles that should be considered in clinical proteomic studies, including sample selection, choice of technology and appropriate quality control, and the need for collaborative interdisciplinary efforts involving clinicians and scientists. Furthermore, we propose guidelines for the critical aspects that should be included in published reports. Our hope is that, as a result of stimulating discussion, a consensus will be reached amongst the scientific community leading to guidelines for the studies, similar to those already published for mass spectrometric sequencing data. We contend that clinical proteomics is not just a collection of studies dealing with analysis of clinical samples. Rather, the essence of clinical proteomics should be to address clinically relevant questions and to improve the state‐of‐the‐art, both in diagnosis and in therapy of diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867
An updated coronary risk profile. A statement for health professionals.
Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
Mass spectrometry–based proteomics turns quantitative
Ong, S.-E., & Mann, M. (2005) · Nature Chemical Biology · doi:10.1038/nchembio736 · Cited by 1,572
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Wang, W., Zhou, H., Lin, H., Roy, S., Shaler, T. A., Hill, L. R., Norton, S., Kumar, P., Anderle, M., & Becker, C. H. (2003) · Analytical Chemistry · doi:10.1021/ac026468x · Cited by 653
Prostate‐specific antigen: A review of the validation of the most commonly used cancer biomarker
Hernández, J., & Thompson, I. M. (2004) · Cancer · doi:10.1002/cncr.20480 · Cited by 527
Bias as a threat to the validity of cancer molecular-marker research
Ransohoff, D. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1550 · Cited by 487
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.2.671 · Cited by 431
Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis
Theodorescu, D., Wittke, S., Ross, M. M., Walden, M., Conaway, M., Just, I., Mischak, H., & Frierson, H. F. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70584-8 · Cited by 410
Self-citationProtein identification using sequential ion/ion reactions and tandem mass spectrometry
Coon, J. J., Ueberheide, B., Syka, J. E. P., Dryhurst, D. D., Ausio, J., Shabanowitz, J., & Hunt, D. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503189102 · Cited by 373
Self-citationROC Curves in Clinical Chemistry: Uses, Misuses, and Possible Solutions
Obuchowski, N. A., Lieber, M. L., & Wians, F. H. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.031823 · Cited by 358
Semmes, O. J., Feng, Z., Adam, B.-L., Banez, L. L., Bigbee, W. L., Campos, D., Cazares, L. H., Chan, D. W., Grizzle, W. E., Izbicka, E., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.038950 · Cited by 343
Self-citationDecramer, S., Wittke, S., Mischak, H., Zürbig, P., Walden, M., Bouissou, F., Bascands, J.-L., & Schanstra, J. P. (2006) · Nature Medicine · doi:10.1038/nm1384 · Cited by 274
Self-citationEvaluation of saturation labelling two‐dimensional difference gel electrophoresis fluorescent dyes
Shaw, J., Rowlinson, R., Nickson, J., Stone, T., Sweet, A., Williams, K., & Tonge, R. (2003) · PROTEOMICS · doi:10.1002/pmic.200300439 · Cited by 264
Reporting Protein Identification Data
Bradshaw, R. A., Burlingame, A. L., Carr, S., & Aebersold, R. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.e600005-mcp200 · Cited by 222
Schaub, S., Wilkins, J. A., Antonovici, M., Krokhin, O., Weiler, T., Rush, D., & Nickerson, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00766.x · Cited by 203
Zürbig, P., Renfrow, M. B., Schiffer, E., Novak, J., Walden, M., Wittke, S., Just, I., Pelzing, M., Neusüß, C., Theodorescu, D., et al. (2006) · ELECTROPHORESIS · doi:10.1002/elps.200500827 · Cited by 193
Self-citationBaker, S. G. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.511 · Cited by 166
Proteomics: From Basic Research to Diagnostic Application. A Review of Requirements & Needs
Vitzthum, F., Behrens, F., Anderson, N. L., & Shaw, J. H. (2005) · Journal of Proteome Research · doi:10.1021/pr050080b · Cited by 165
Serum Levels of an Isoform of Apolipoprotein A-II as a Potential Marker for Prostate Cancer
Malik, G., Ward, M. D., Gupta, S. K., Trosset, M. W., Grizzle, W. E., Adam, B.-L., Diaz, J. I., & Semmes, O. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1073.11.3 · Cited by 158
Self-citationRoessler, M., Rollinger, W., Mantovani-Endl, L., Hagmann, M., Palme, S., Berndt, P., Engel, A. M., Pfeffer, M., Karl, J., Bodenmüller, H., et al. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600118-mcp200 · Cited by 144
Candiano, G., Musante, L., Bruschi, M., Petretto, A., Santucci, L., Boccio, P. D., Pavone, B., Perfumo, F., Urbani, A., Scolari, F., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050486 · Cited by 140
Parodi, S., Izzotti, A., & Muselli, M. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji034 · Cited by 136
Wittke, S., Haubitz, M., Walden, M., Rohde, F., Schwarz, A., Mengel, M., Mischak, H., Haller, H. G., & Gwinner, W. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01053.x · Cited by 134
Self-citationSchiffer, E., Mischak, H., & Novák, J. (2006) · PROTEOMICS · doi:10.1002/pmic.200600230 · Cited by 98
Self-citationEvaluating markers for the early detection of cancer: overview of study designs and methods
Baker, S. G., Kramer, B. S., McIntosh, M. W., Patterson, B. H., Shyr, Y., & Skates, S. J. (2006) · Clinical Trials · doi:10.1191/1740774506cn130oa · Cited by 76
The Work of the Human Proteome Organisation's Proteomics Standards Initiative (HUPO PSI)
Taylor, C. F., Hermjakob, H., Julian, R. K., Garavelli, J. S., Aebersold, R. H., & Apweiler, R. (2006) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2006.10.145 · Cited by 74
Self-citationGood Clinical Laboratory Practice (GCLP)
TDR (2009) · World Health Organization eBooks · doi:10.2471/tdr.09.978-924-1597852 · Cited by 28
Lapolla, A., Tubaro, M., Fedele, D., Reitano, R., Aricò, C. N., Ragazzi, E., Seraglia, R., Vogliardi, S., & Traldi, P. (2004) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1759 · Cited by 27
Cited by
The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences
Perez-Riverol, Y., Bai, J., Bandla, C., García-Seisdedos, D., Hewapathirana, S., Kamatchinathan, S., Kundu, D. J., Prakash, A., Frericks-Zipper, A., Eisenacher, M., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1038 · Cited by 6,125
Isotope-labeled Protein Standards
Brun, V., Dupuis, A., Adrait, A., Marcellin, M., Thomas, D., Court, M., Vandenesch, F., & Garin, J. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700163-mcp200 · Cited by 445
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Mischak, H., Allmaier, G., Apweiler, R., Attwood, T., Baumann, M., Benigni, A., Bennett, S. E., Bischoff, R., Bongcam-Rudloff, E., Capasso, G., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001249 · Cited by 334
Self-citationAdvances in Urinary Proteome Analysis and Biomarker Discovery
Fliser, D., Novak, J., Thongboonkerd, V., Argile[Combining Acute Accent]s, A. G. A., Jankowski, V., Girolami, M. A., Jankowski, J., & Mischak, H. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006090956 · Cited by 286
Self-citationPractical Points in Urinary Proteomics
Thongboonkerd, V. (2007) · Journal of Proteome Research · doi:10.1021/pr070328s · Cited by 208
Self-citation
Metadata
- Authors
- Mischak, H., Apweiler, R., Banks, R. E., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J. H. H., Fliser, D., Girolami, M., Hermjakob, H., Hochstrasser, D., Jankowski, J., Julian, B. A., Kolch, W., Massy, Z. A., Neusuess, C., Novak, J., Peter, K., Rossing, K., Schanstra, J., Semmes, O. J., Theodorescu, D., Thongboonkerd, V., Weissinger, E. M., Van Eyk, J. E., & Yamamoto, T.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2007-02
- Volume
- 1
- Issue
- 2
- Pages
- 148-156
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W1992271070
- Cited by
- 307
- References
- 30
- FWCI
- 22.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.